EASTGATE BIOTECH RECEIVES NOTICE OF PUBLICATION FROM THE US PATENT AND TRADEMARK OFFICE FOR TWO PATENTS FOR THE COMPANY’S PROPRIETARY INTRAORAL LORAZEPAM SPRAY
Read moreShortly before I completed this column, I talked to a paraplegic patient who must use a catheter regularly to empty her bladder. This resulted in repeated infections in spite of five different antibiotics! She reported that use of UTI E-Drops resolved her dilemma.
Read morePreferred Nutrition placed an order for E-drops which is the company’s natural and herbal alternative that assists to rid the body of UTI infections painlessly and effectively without side effects of synthetic drugs.
Read moreTo date, the company is successfully advancing in a formulation development of a 25 IU intraoral insulin tablet, designed to manage mealtime glucose levels.
Read moreEASTGATE BIOTECH CREATES AN ONLINE DIRECTORY AS A MARKETING TOOL FOR ITS NUTRACEUTICAL PRODUCT
Read morePreviously the company announced that its research collaboration with the University of Guelph involved measuring the antimicrobial activity of the company's natural antibacterial products, Cleanezze™ and Vclean™
Read moreEastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company has announced that Impex Healthcare (www.ImpexHealthcare.com) will commence the distribution and marketing of one of the company’s natural products, Glucora, in Bangladesh along with future distribution of other glucose management products.
Read moreEastGate Biotech Corp. (OTCBB: ETBI), has announced today its collaboration with the University of Guelph, Canada, Department of Molecular and Cellular Biology. The collaboration involves evaluation of the antimicrobial activity of the company’s natural antibacterial products, Cleanezze™ and VClean™.
Read morePharmaCenter Ltd. successfully registered E-drops with the local health authority in Slovakia and placed an initial sample order for E-drops which is the company’s natural and herbal alternative that assists to rid the body of UTI infections painlessly and effectively without side effects of synthetic drugs. The initial sample order will be used for test marketing and launch in Slovakia initially before entering into the other respective markets.
Read moreSALT LAKE CITY and TORONTO, March 11, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules has received a purchase order from ...
Read more